These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9504640)

  • 1. Two cases of inv(8)(p11q13) in AML with erythrophagocytosis: a new cytogenetic variant.
    Coulthard S; Chase A; Orchard K; Watmore A; Vora A; Goldman JM; Swirsky DM
    Br J Haematol; 1998 Mar; 100(3):561-3. PubMed ID: 9504640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia with inv(8)(p11q13).
    Panagopoulos I; Teixeira MR; Micci F; Hammerstrøm J; Isaksson M; Johansson B; Mitelman F; Heim S
    Leuk Lymphoma; 2000 Nov; 39(5-6):651-6. PubMed ID: 11342350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement.
    Aguiar RC; Chase A; Coulthard S; Macdonald DH; Carapeti M; Reiter A; Sohal J; Lennard A; Goldman JM; Cross NC
    Blood; 1997 Oct; 90(8):3130-5. PubMed ID: 9376594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic and molecular remission in a case of acute myeloid leukaemia(AML) with inversion of chromosome 16 (Inv(16)) and Philadelphia chromosome (Ph).
    Preudhomme C; Lai JL; Plantier I; Demory JL; Zandecki M; Fenaux P
    Br J Haematol; 1992 Nov; 82(3):623-6. PubMed ID: 1486046
    [No Abstract]   [Full Text] [Related]  

  • 5. Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation.
    Rozman M; Camós M; Colomer D; Villamor N; Esteve J; Costa D; Carrió A; Aymerich M; Aguilar JL; Domingo A; Solé F; Gomis F; Florensa L; Montserrat E; Campo E
    Genes Chromosomes Cancer; 2004 Jun; 40(2):140-5. PubMed ID: 15101047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consistent fusion of MOZ and TIF2 in AML with inv(8)(p11q13).
    Carapeti M; Aguiar RC; Watmore AE; Goldman JM; Cross NC
    Cancer Genet Cytogenet; 1999 Aug; 113(1):70-2. PubMed ID: 10459350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic characterization of acute myeloid leukemia with cytogenetic or molecular evidence of t(8;21), t(15;17), inv(16) and 11q23 abnormalities.
    Rozman M; Navarro JT; Domingo A; Ayats R; Vallespí T; Gallart M; Florensa L;
    Haematologica; 2002 Aug; 87(8):886-7. PubMed ID: 12161368
    [No Abstract]   [Full Text] [Related]  

  • 8. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?
    Dissing M; Le Beau MM; Pedersen-Bjergaard J
    J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic characterization of MOZ/CBP and CBP/MOZ chimeras in acute myeloid leukemia suggests the involvement of a damage-repair mechanism in the origin of the t(8;16)(p11;p13).
    Panagopoulos I; Isaksson M; Lindvall C; Hagemeijer A; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2003 Jan; 36(1):90-8. PubMed ID: 12461753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.
    Prébet T; Boissel N; Reutenauer S; Thomas X; Delaunay J; Cahn JY; Pigneux A; Quesnel B; Witz F; Thépot S; Ugo V; Terre C; Recher C; Tavernier E; Hunault M; Esterni B; Castaigne S; Guilhot F; Dombret H; Vey N; ; ;
    J Clin Oncol; 2009 Oct; 27(28):4747-53. PubMed ID: 19720919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of therapy-related acute myeloid leukemia associated with inv(16), with subsequent development of t(9;22).
    Kim M; Lim J; Kim Y; Han K; Kang CS; Kim HJ; Min WS
    Leukemia; 2006 Apr; 20(4):746-8. PubMed ID: 16437154
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)].
    Perea G; Lasa A; Aventín A; Domingo A; Villamor N; Queipo de Llano MP; Llorente A; Juncà J; Palacios C; Fernández C; Gallart M; Font L; Tormo M; Florensa L; Bargay J; Martí JM; Vivancos P; Torres P; Berlanga JJ; Badell I; Brunet S; Sierra J; Nomdedéu JF;
    Leukemia; 2006 Jan; 20(1):87-94. PubMed ID: 16281071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.
    Quesnel B; Kantarjian H; Bjergaard JP; Brault P; Estey E; Lai JL; Tilly H; Stoppa AM; Archimbaud E; Harousseau JL
    J Clin Oncol; 1993 Dec; 11(12):2370-9. PubMed ID: 8246025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16.
    Marlton P; Keating M; Kantarjian H; Pierce S; O'Brien S; Freireich EJ; Estey E
    Leukemia; 1995 Jun; 9(6):965-71. PubMed ID: 7596186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of minimally differentiated acute myeloid leukemia with chromosome 16 inversion.
    Sotomatsu M; Ogawa C; Shimoda M; Matsui A; Nakazawa S; Eguchi M; Morikawa A
    Leuk Lymphoma; 1997 Jan; 24(3-4):319-25. PubMed ID: 9156661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A further case of acute myeloid leukaemia with inv(8)(p11q13) and MOZ-TIF2 fusion.
    Billio A; Steer EJ; Pianezze G; Svaldi M; Casin M; Amato B; Coser P; Cross NC
    Haematologica; 2002 May; 87(5):ECR15. PubMed ID: 12010678
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia.
    Rowe D; Cotterill SJ; Ross FM; Bunyan DJ; Vickers SJ; Bryon J; McMullan DJ; Griffiths MJ; Reilly JT; Vandenberghe EA; Wilson G; Watmore AE; Bown NP
    Br J Haematol; 2000 Dec; 111(4):1051-6. PubMed ID: 11167739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A further case of acute myelomonocytic leukemia with inv(8) chromosomal rearrangement and MOZ-NCOA2 gene fusion.
    Murati A; Adélaïde J; Popovici C; Mozziconacci MJ; Arnoulet C; Lafage-Pochitaloff M; Sainty D; Birnbaum D; Chaffanet M
    Int J Mol Med; 2003 Oct; 12(4):423-8. PubMed ID: 12964013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research Council.
    Langabeer SE; Grimwade D; Walker H; Rogers JR; Burnett AK; Goldstone AH; Linch DC
    Br J Haematol; 1998 May; 101(2):338-40. PubMed ID: 9609531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bulky lymphadenopathy in acute myeloid leukemia with inv (16) (p13q22): a case report].
    Zhou HF; Li JY; Qian SX; Qiu HR; Zhang SJ; Zhang JF; Wu YJ; Shen RL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):1033-7. PubMed ID: 17096914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.